FDA Label for Psorinoheel
View Indications, Usage & Precautions
Psorinoheel Product Label
The following document was submitted to the FDA by the labeler of this product Heel Inc. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Description
Each1.1 ml ampule contains:
Ingredient Name | Potency | Quantity |
Bacillinum | 12x | 0.55µ |
Bufo rana | 10x | 1.1µ |
Cictuta virosa | 5x | 0.55µ |
Kali bismuthum iodatum | 5x | 0.55 µ |
Medorrhinum | 12x | 1.1µ |
Natrum muriaticum | 12x | 1.1µ |
Oleander | 4x | 0.55µ |
Psorinum | 10x | 1.1µ |
Sulphur | 6x | 1.1µ |
Thuja occidentalis | 6x | 1.1µ |
Vaccinotoxinum | 8x | 1.1µ |
Inactive Ingredient: Isotonic Sodium Chloride solution
Indication And Usage
Psorinoheel® Oral Vials is a homeopathic drug product indicated for the stimulation of the defense mechanism in chronic skin disorders, hepatic damage , and chronic illness
Dosage And Administration
Dosage:
Adults and children above 6 years: 1 vial orally 1-3 times daily
Children up to 6 years: ½ vial orally 1-3 times daily
Contraindications
Contraindications
Psorinoheel® Oral Vials are contraindicated in patients with known hypersensitivity to Psorinoheel® or any of its ingredients.
Warnings And Precautions
Warnings and Precautions
None
Adverse Reactions
No adverse events have been reported with a causal relationship Psorinoheel® Oral Vials.
Overdosage
Overdosage: No negative effects of an overdose have been reported and none are expected due to the homeopathic dilutions
Clinical Pharmacology
Mechanism of Action
The exact mechanism of Psorinoheel®Oral Vials is not fully understood.
Pharmacodynamics
Not applicable for homeopathic medicinal products.
Dosage
1 oral vial containing 1.1 ml solution for oral administration
* Please review the disclaimer below.